Get the Stockscreener App
0.0937
0.76%
0.0019
After Hours:
.09
-0.0037
-3.95%
Cns Pharmaceuticals Inc Stock (CNSP) Forecast
The Cns Pharmaceuticals Inc (CNSP) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $11.27, representing a +11,922% increase from the current price of $0.0937. The highest analyst price target is $16.51, and the lowest is $6.0208.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CNSP Price Target
Average 18.81
(+19,974% Upside)
Is Cns Pharmaceuticals Inc (CNSP) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 39.71 | Neutral |
| STOCH(9,6) | 42.56 | Neutral |
| STOCHRSI(14) | 34.80 | Neutral |
| MACD(12,26) | -0.00473 | Sell |
| ADX(14) | 17.84 | Neutral |
| William %R | -62.16 | Neutral |
| CCI(14) | -47.12 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.0974
Sell
|
0.0972
Sell
|
| MA20 |
0.1023
Sell
|
0.1011
Sell
|
| MA50 |
0.1075
Sell
|
0.1279
Sell
|
| MA100 |
0.1181
Sell
|
1.0045
Sell
|
| MA200 |
2.0172
Sell
|
9.3311
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, CNSP could be considered a Strong Sell, with 17 technical analysis indicators signaling 0 Buy signals, 11 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on CNSP, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 39.71 indicates that CNSP is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 42.56 indicates that CNSP is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 34.8 indicates that CNSP is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 17.84 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -47.12 indicates that CNSP is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term CNSP price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Cns Pharmaceuticals Inc financial reports and earnings history, Cns Pharmaceuticals Inc (CNSP) stock could reach $38.97 by 2030, $70.10 by 2040 and $319.69 by 2050. See the projected annual prices until 2050 of the Cns Pharmaceuticals Inc stock below:
- Cns Pharmaceuticals Inc (CNSP) is expected to reach an average price of $74.03 in 2035, with a high prediction of $75.20 and a low estimate of $74.62. This indicates an $78,906% rise from the last recorded price of $0.0937.
- Cns Pharmaceuticals Inc (CNSP) stock is projected to chart a bullish course in 2040, with an average price target of $68.15, representing an $72,631% surge from its current level. The forecast ranges from a conservative $68.22 to a sky-high $70.10.
- Our analysts predict Cns Pharmaceuticals Inc (CNSP) to jump 37,124% by 2045, soaring from $36.04 to an average price of $34.88, potentially reaching $39.12. While $36.04 is the low estimate, the potential upside is significant.
- Cns Pharmaceuticals Inc (CNSP) stock is expected to climb by 2050, reaching an average of $319.80, a $341.21K% jump from its current level. However, a wide range of estimates exists, with high and low targets of $319.69 and $322.20, respectively, highlighting the market's uncertainty.
Cns Pharmaceuticals Inc Stock (CNSP) Year by Year Forecast
Cns Pharmaceuticals Inc Stock (CNSP) Price Forecast for 2025
Cns Pharmaceuticals Inc Stock (CNSP) is expected to reach an average price of $25.20 in 2025, with a high prediction of $49.96 and a low estimate of $0.438. This indicates an +26,792% rise from the last recorded price of $0.0937.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $11.02 | $6.0208 | $16.51 | +11,665% |
| April, 2025 | $15.58 | $10.38 | $37.18 | +16,529% |
| May, 2025 | $11.19 | $6.784 | $16.94 | +11,839% |
| June, 2025 | $3.7929 | $0.4929 | $11.91 | +3,948% |
| July, 2025 | $6.5502 | $3.5502 | $10.94 | +6,891% |
| August, 2025 | $6.0561 | $1.8032 | $9.4532 | +6,363% |
| September, 2025 | $0.138 | $0.438 | $7.8076 | +47.27% |
| October, 2025 | $6.8306 | $1.0865 | $6.9649 | +7,190% |
| November, 2025 | $14.60 | $9.7292 | $9.0107 | +15,485% |
| December, 2025 | $16.39 | $14.38 | $15.43 | +17,389% |
Cns Pharmaceuticals Inc Stock (CNSP) Price Forecast for 2026
The predicted value for Cns Pharmaceuticals Inc (CNSP) in 2026 is set at an average of $19.55. Estimates vary from a peak of $22.86 to a trough of $16.25, indicating an +20,769% surge from the present price of $0.0937.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $23.21 | $21.54 | $22.86 | +24,669% |
| February, 2026 | $22.51 | $23.23 | $22.22 | +23,919% |
| March, 2026 | $20.60 | $21.75 | $21.15 | +21,888% |
| April, 2026 | $21.45 | $20.62 | $20.43 | +22,790% |
| May, 2026 | $19.42 | $20.50 | $20.76 | +20,622% |
| June, 2026 | $19.73 | $20.38 | $19.97 | +20,957% |
| July, 2026 | $20.28 | $19.98 | $19.81 | +21,546% |
| August, 2026 | $18.15 | $19.23 | $19.27 | +19,265% |
| September, 2026 | $18.86 | $17.81 | $17.52 | +20,024% |
| October, 2026 | $18.04 | $18.04 | $17.93 | +19,152% |
| November, 2026 | $16.93 | $17.20 | $17.76 | +17,966% |
| December, 2026 | $18.55 | $16.25 | $18.47 | +19,698% |
Cns Pharmaceuticals Inc Stock (CNSP) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Cns Pharmaceuticals Inc (CNSP) is $12.20, with a high forecast of $18.02 and a low forecast of $6.3775. This indicates an +12,919% increase from the last price of $0.0937.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $17.43 | $17.98 | $18.02 | +18,507% |
| February, 2027 | $17.12 | $17.17 | $17.28 | +18,170% |
| March, 2027 | $16.22 | $16.51 | $16.54 | +17,212% |
| April, 2027 | $15.93 | $16.08 | $15.93 | +16,897% |
| May, 2027 | $14.17 | $14.38 | $15.63 | +15,023% |
| June, 2027 | $12.96 | $13.18 | $13.71 | +13,734% |
| July, 2027 | $11.64 | $11.88 | $12.67 | +12,319% |
| August, 2027 | $10.65 | $10.67 | $11.14 | +11,267% |
| September, 2027 | $9.5034 | $9.5634 | $10.29 | +10,042% |
| October, 2027 | $8.8375 | $8.8475 | $9.2519 | +9,332% |
| November, 2027 | $8.3816 | $8.5016 | $8.556 | +8,845% |
| December, 2027 | $6.1943 | $6.3775 | $8.0202 | +6,511% |
Cns Pharmaceuticals Inc Stock (CNSP) Price Forecast for 2028
In 2028, Cns Pharmaceuticals Inc (CNSP) is projected to reach an average price of $27.77, with a high projection of $55.28 and a low estimate of $0.2653. This indicates an +29,541% rise from the last price of $0.0937.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $4.8784 | $5.2984 | $5.8848 | +5,106% |
| February, 2028 | $4.5225 | $4.584 | $4.627 | +4,727% |
| March, 2028 | $4.2152 | $4.3466 | $4.3495 | +4,399% |
| April, 2028 | $3.7112 | $3.752 | $4.0747 | +3,861% |
| May, 2028 | $2.302 | $2.4119 | $3.4206 | +2,357% |
| June, 2028 | $1.4674 | $1.476 | $2.0024 | +1,466% |
| July, 2028 | $0.5087 | $0.5201 | $1.195 | +442.96% |
| August, 2028 | $39.48 | $0.2653 | $55.28 | +42,034% |
| September, 2028 | $52.17 | $45.58 | $46.47 | +55,575% |
| October, 2028 | $49.56 | $52.86 | $50.56 | +52,788% |
| November, 2028 | $40.44 | $43.74 | $49.05 | +43,060% |
| December, 2028 | $34.23 | $37.03 | $36.04 | +36,431% |
Cns Pharmaceuticals Inc Stock (CNSP) Price Forecast for 2029
The 2029 price forecast for Cns Pharmaceuticals Inc Stock (CNSP) is $23.76 on average, with a high prediction of $44.01 and a low estimate of $3.5003. This represents an +25,255% increase from the previous price of $0.0937.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $45.21 | $32.30 | $44.01 | +48,154% |
| February, 2029 | $3.2974 | $42.71 | $39.61 | +3,419% |
| March, 2029 | $24.99 | $3.5003 | $36.80 | +26,571% |
| April, 2029 | $21.78 | $16.43 | $20.28 | +23,143% |
| May, 2029 | $30.96 | $22.48 | $27.06 | +32,946% |
| June, 2029 | $33.45 | $34.95 | $32.96 | +35,602% |
| July, 2029 | $24.84 | $27.54 | $25.94 | +26,411% |
| August, 2029 | $31.03 | $29.14 | $28.93 | +33,012% |
| September, 2029 | $37.41 | $33.92 | $32.50 | +39,830% |
| October, 2029 | $33.40 | $32.31 | $30.41 | +35,545% |
| November, 2029 | $32.89 | $35.79 | $33.39 | +34,999% |
| December, 2029 | $38.08 | $33.58 | $33.88 | +40,536% |
Cns Pharmaceuticals Inc Stock (CNSP) Price Forecast for 2030
Cns Pharmaceuticals Inc Stock (CNSP) is expected to reach an average price of $47.65 in 2030, with a high forecast of $56.53 and a low forecast of $38.77. This signifies an +50,753% surge from the last price of $0.0937.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $43.51 | $38.77 | $38.97 | +46,337% |
| February, 2030 | $50.28 | $45.96 | $44.69 | +53,558% |
| March, 2030 | $51.84 | $49.80 | $49.24 | +55,221% |
| April, 2030 | $57.21 | $51.57 | $56.53 | +60,956% |
| May, 2030 | $54.91 | $55.84 | $56.03 | +58,503% |
| June, 2030 | $52.00 | $53.39 | $53.04 | +55,399% |
| July, 2030 | $51.59 | $51.49 | $50.57 | +54,959% |
| August, 2030 | $48.55 | $49.63 | $50.65 | +51,717% |
| September, 2030 | $47.86 | $48.52 | $48.60 | +50,979% |
| October, 2030 | $47.16 | $47.61 | $47.33 | +50,226% |
| November, 2030 | $44.01 | $45.10 | $45.89 | +46,872% |
| December, 2030 | $42.58 | $42.67 | $43.13 | +45,346% |
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):